CIMA Shareholder Suits Follow Firm’s Rejection Of Cephalon Merger Offer
This article was originally published in The Tan Sheet
Executive Summary
Two class action shareholder lawsuits filed after CIMA Labs rejected Cephalon's acquisition offer could complicate the firm's proposed merger with aaiPharma